We previously showed that high MD was associated with HER2-enriched and luminal B breast cancer subtypes among Chinese breast cancer patients [8, 9], and that reduced TDLU involution was associated with basal-like or triple-negative subtypes among European, Black, and Chinese breast cancer patients [10–12]. This evidence concerns the gene ERBB2 and breast cancer.